156 related articles for article (PubMed ID: 321297)
1. [A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive].
Ruíz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
Ginecol Obstet Mex; 1977 Feb; 41(244):179-84. PubMed ID: 321297
[TBL] [Abstract][Full Text] [Related]
2. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
3. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup J; Bostofte E; Larsen S; Westergaard J
Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.
Harada T; Momoeda M; Terakawa N; Taketani Y; Hoshiai H
Fertil Steril; 2011 May; 95(6):1928-31. PubMed ID: 21420678
[TBL] [Abstract][Full Text] [Related]
5. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
Moggia AV
J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with a low-dose contraceptive agent. European studies.
Haspels AA
J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
[TBL] [Abstract][Full Text] [Related]
7. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
[TBL] [Abstract][Full Text] [Related]
9. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
Woutersz TB
J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254
[TBL] [Abstract][Full Text] [Related]
10. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
Hampton RM; Fisher AC; Pagano S; LaGuardia KD
Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
[TBL] [Abstract][Full Text] [Related]
11. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
Rubio-Lotvin B; Gonzales-Ansorena R
Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
[TBL] [Abstract][Full Text] [Related]
12. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
Woutersz TB
J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
[TBL] [Abstract][Full Text] [Related]
13. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
Shoupe D
Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Nakajima ST; Archer DF; Ellman H
Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
[TBL] [Abstract][Full Text] [Related]
15. Three and one-half years' experience with a lower-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
[TBL] [Abstract][Full Text] [Related]
16. Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
Nakajima ST; Pappadakis J; Archer DF
Contraception; 2016 Jan; 93(1):52-7. PubMed ID: 26410176
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
Weijers MJ
Fortschr Med; 1982 Apr; 100(16):764-7. PubMed ID: 6211403
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
Friedman AJ; Wheeler J
J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
[TBL] [Abstract][Full Text] [Related]
19. [Results of the use of an estrogen-progestagen combination at low dosage as a contraceptive. Preliminary report].
Ruiz Moreno JA; Rubio Lotvin B; Bolio Arista R
Ginecol Obstet Mex; 1973 Jul; 34(201):35-42. PubMed ID: 4727872
[No Abstract] [Full Text] [Related]
20. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
